Tepmetko Europos Sąjunga - slovakų - EMA (European Medicines Agency)

tepmetko

merck europe b.v. - tepotinib hydrochloride monohydrate - karcinóm, pľúc bez malých buniek - antineoplastické činidlá - tepmetko as monotherapy is indicated for the treatment of adult patients with advanced non-small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal-epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum-based chemotherapy.

Erlotinib Teva 150 mg filmom obalené tablety Slovakija - slovakų - ŠÚKL (Štátny ústav pre kontrolu liečiv)

erlotinib teva 150 mg filmom obalené tablety

teva pharmaceuticals slovakia s.r.o., slovensko - erlotinib - 44 - cytostatica

Erlotinib Teva 100 mg filmom obalené tablety Slovakija - slovakų - ŠÚKL (Štátny ústav pre kontrolu liečiv)

erlotinib teva 100 mg filmom obalené tablety

teva pharmaceuticals slovakia s.r.o., slovensko - erlotinib - 44 - cytostatica